Schonfeld Strategic Advisors’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,457
| Closed | -$685K | – | 2223 |
|
|
2025
Q1 | $685K | Buy |
33,457
+13,075
| +64% | +$268K | ﹤0.01% | 1336 |
|
|
2024
Q4 | $524K | Buy |
+20,382
| New | +$524K | ﹤0.01% | 1311 |
|
|
2024
Q3 | – | Sell |
-49,433
| Closed | -$950K | – | 2097 |
|
|
2024
Q2 | $950K | Sell |
49,433
-72,567
| -59% | -$1.39M | 0.01% | 1109 |
|
|
2024
Q1 | $2.89M | Buy |
122,000
+55,100
| +82% | +$1.3M | 0.02% | 712 |
|
|
2023
Q4 | $747K | Buy |
66,900
+2,200
| +3% | +$24.6K | 0.01% | 1067 |
|
|
2023
Q3 | $598K | Buy |
64,700
+7,400
| +13% | +$68.5K | ﹤0.01% | 1037 |
|
|
2023
Q2 | $681K | Buy |
57,300
+27,200
| +90% | +$323K | 0.01% | 1085 |
|
|
2023
Q1 | $399K | Buy |
+30,100
| New | +$399K | ﹤0.01% | 1239 |
|